HeimAFX • ETR
add
Carl Zeiss Meditec AG
Við síðustu lokun
46,96 €
Dagbil
45,98 € - 47,28 €
Árabil
44,74 € - 123,75 €
Markaðsvirði
4,13 ma. EUR
Meðalmagn
233,05 þ.
V/H-hlutf.
22,94
A/V-hlutfall
-
Aðalkauphöll
ETR
Viðskiptafréttir
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (EUR) | sep. 2024info | Breyting á/á |
|---|---|---|
Tekjur | 579,63 m. | -0,01% |
Rekstrarkostnaður | 266,12 m. | 12,28% |
Nettótekjur | 60,73 m. | -28,72% |
Hagnaðarhlutfall | 10,48 | -28,71% |
Hagnaður á hvern hlut | 1,01 | -0,48% |
EBITDA | 33,42 m. | -69,25% |
Virkt skatthlutfall | 9,50% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (EUR) | sep. 2024info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 20,28 m. | 91,35% |
Heildareignir | 3,39 ma. | 11,88% |
Heildarskuldir | 1,34 ma. | 55,43% |
Eigið fé alls | 2,06 ma. | — |
Útistandandi hlutabréf | 87,54 m. | — |
Eiginfjárgengi | 2,01 | — |
Arðsemi eigna | — | — |
Ávöxtun eigin fjár | 2,47% | — |
Peningaflæði
Breyting á handbæru fé
| (EUR) | sep. 2024info | Breyting á/á |
|---|---|---|
Nettótekjur | 60,73 m. | -28,72% |
Handbært fé frá rekstri | — | — |
Reiðufé frá fjárfestingum | — | — |
Reiðufé frá fjármögnun | — | — |
Breyting á handbæru fé | — | — |
Frjálst peningaflæði | — | — |
Um
Carl Zeiss Meditec AG is a multinational medical technology company and subsidiary of Carl Zeiss AG. It manufactures tools for eye examinations and medical lasers as well as solutions for neurosurgery, dentistry, gynecology and oncology. Among its products are the most common tools used by ophthalmologists and optometrists.
In October 2018, Carl Zeiss Meditec won FDA premarket approval for its ReLEx Smile laser system.
Also in October 2018, Carl Zeiss Meditec announced the acquisition of Reno, Nevada-based IanTech for an undisclosed sum.
In September 2019, Carl Zeiss Meditec launched the CIRRUS 6000 at the European Society of Retina Specialists 2019 Congress. Wikipedia
Framkvæmdastjóri
Stofnsett
2002
Höfuðstöðvar
Starfsfólk
5.730
